Use of microRNA signature to predict patient sensitivity to dendritic cell vaccination in metastatic melanoma.

8591 Background: One recently developed strategy in treating patients with stage IV melanoma consists of dendritic cell (DC) vaccination. This therapy has variable results, based on patients’ immun...